Tci Wealth Advisors, Inc. Ocular Therapeutix, Inc Transaction History

Tci Wealth Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	SELL	$2.79 - $6.27 $279 - $627	-100 Reduced 50.0%	100 $0
Q1 2022 Apr 29, 2022	SELL	$4.83 - $7.35 $3,004 - $4,571	-622 Reduced 75.67%	200 $1,000
Q4 2021 Jan 24, 2022	BUY	$6.16 - $12.07 $5,063 - $9,921	822 New	822 $6,000
Q2 2021 Aug 02, 2021	SELL	$13.43 - $19.16 $1,329 - $1,896	-99 Closed	0 $0
Q1 2021 Apr 29, 2021	BUY	$15.82 - $22.11 $1,566 - $2,188	99 New	99 $2,000

148

123M

185K

507K

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $526M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.